InsidersTradesSigma
Browse the detailed record of transactions filed by Calamari Christopher J., Chief Executive Officer. Officer active across 1 companies, notably Abbott Laboratories. In total, 5 disclosures have been published. The latest transaction was disclosed on 1 July 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Christopher J. Calamari is the CEO at Abbott Laboratories. He is responsible for the strategic and operational direction of the company. His role includes managing resources and making key decisions to ensure growth and profitability. Through his leadership, he guides the company towards achieving its long-term objectives.